Episode
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1
- Published
- Jul 27, 2026
- Duration seconds
- 1337
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Mazyar Shadman, including the following topics: The CLL17 trial: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia (CLL) (0:00) The AMPLIFY trial: Fixed-duration acalabrutinib combinations for untreated CLL (5:31) Zanubrutinib-based therapy for treatment-naïve CLL (12:32) CME information and select publications